Semaglutide, available as a once-weekly injection or in newer tablet forms, offers a flexible approach to weight loss
The Benefits Far Outweigh the Risks For most patients, the benefits of GLP-1 agonists far outweigh the potential risks
This should include measurement of thyroid-stimulating hormone (TSH) and, if not previously documented, free thyroxine (free T4) levels
No sucrose preference changes occurred
High rates of attrition (12%) were observed in Altimmunes trials, and 5% of patients on semaglutide discontinued treatment due to nausea, vomiting or diarrhea (with 25-44% of patients reporting symptoms)
Intro to the Wegovy Lawsuit The allegations in the lawsuit revolve around the drug manufacturers alleged negligence in failing to warn patients about the potential risk of stomach paralysis